CPHI [CHINA PHARMAS,] UPLOAD: (Original Filing)
[]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Reports Unaudited Fourth Quarter and Preliminary Full Year 2009 Record Financial Results - Conference call scheduled Tuesday, April 6, 2010 at 9:00 a.m. EDT - - Provides full year 2010 sales guidance of $67.1 million to $72.5 million - BEIJING, April 6 /PRNewswire-Asia/ Sinovac Biotech Ltd. ( Nasdaq: SVA), a leading China-based vaccine manufacturer, announc ed today its] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, Peoples Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]
CPHI [CHINA PHARMAS,] PRE 14C: SCHEDULE 14C INFORMATION Check the appropriate box: [X]
[SCHEDULE 14C INFORMATION Check the appropriate box: [X] Preliminary Information Statement [] [] Definitive Information Statement [Missing Graphic Reference] Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]
CPHI [CHINA PHARMAS,] PRE 14C: (Original Filing)
[SCHEDULE 14C INFORMATION Check the appropriate box: [X] Preliminary Information Statement [] [] Definitive Information Statement [Missing Graphic Reference] Payment of Filing Fee (Check the appropriate box): [X] No fee required. [] Feemputed on table below per Exchange Act Rules 14c-5(g) and 0-11. 1) Title of each class of securities to which transaction applies:]
BSPM [Biostar Pharmaceuticals,] 10-K: (Original Filing)
[FORM 10-K x For the fiscal year ended December 31, 2009 OR o to For the transition period from 333-147363 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-5101287 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China 712046 (Zip Code) 011-86-29-33686638 o þ þ o o þ] [Wu Quan Mountain Land Use Transfer Agreement Party A: Village Committee of the Wu Quan Village, Jiang Cun Town, Hu County (Transferor) Party B: Shaanxi Aoxing Pharmaceutical Co., Ltd. (Transferee) I. Party A shall transfer the land use right to Party B of a land sized 9,000 Mou, east border at the center of Shi He, west border at the] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ronghua Wang, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Elaine Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer March 31, 2010 EX-32.1 5 ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Elaine Zhao Chief Financial Officer March 31, 2010 EX-32.2 6 ex32-2.htm]
